Artelo Biosciences Inc.
1.16
0.03 (2.65%)
At close: Jan 15, 2025, 2:26 PM

Artelo Biosciences Statistics

Share Statistics

Artelo Biosciences has 3.23M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 3.23M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 3.20M
Failed to Deliver (FTD) Shares 220
FTD / Avg. Volume 0.65%

Short Selling Information

The latest short interest is 19.93K, so 0.62% of the outstanding shares have been sold short.

Short Interest 19.93K
Short % of Shares Out 0.62%
Short % of Float 0.62%
Short Ratio (days to cover) 1.65

Valuation Ratios

The PE ratio is -0.83 and the forward PE ratio is -1.33.

PE Ratio -0.83
Forward PE -1.33
PS Ratio 0
Forward PS null
PB Ratio 0.42
P/FCF Ratio -1.02
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Artelo Biosciences Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.36, with a Debt / Equity ratio of 0.

Current Ratio 18.36
Quick Ratio 18.36
Debt / Equity 0
Total Debt / Capitalization 0.32
Cash Flow / Debt -127.11
Interest Coverage -2057.4

Financial Efficiency

Return on equity (ROE) is -0.51% and return on capital (ROIC) is -51.75%.

Return on Equity (ROE) -0.51%
Return on Assets (ROA) -0.48%
Return on Capital (ROIC) -51.75%
Revenue Per Employee 0
Profits Per Employee -1.97M
Employee Count 5
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax -209.00K
Effective Tax Rate 0.02

Stock Price Statistics

The stock price has increased by -25% in the last 52 weeks. The beta is 1.35, so Artelo Biosciences 's price volatility has been higher than the market average.

Beta 1.35
52-Week Price Change -25%
50-Day Moving Average 1.11
200-Day Moving Average 1.26
Relative Strength Index (RSI) 56.82
Average Volume (20 Days) 34.05K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -10.29M
Net Income -9.87M
EBITDA -10.29M
EBIT n/a
Earnings Per Share (EPS) -3.49
Full Income Statement

Balance Sheet

The company has 6.89M in cash and 63.00K in debt, giving a net cash position of 6.83M.

Cash & Cash Equivalents 6.89M
Total Debt 63.00K
Net Cash 6.83M
Retained Earnings -31.02M
Total Assets 15.50M
Working Capital 12.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.01M and capital expenditures 0, giving a free cash flow of -8.01M.

Operating Cash Flow -8.01M
Capital Expenditures 0
Free Cash Flow -8.01M
FCF Per Share -2.83
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ARTL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -306.14%
FCF Yield -217.63%
Dividend Details

Analyst Forecast

The average price target for ARTL is $6, which is 426.3% higher than the current price. The consensus rating is "Buy".

Price Target $6
Price Target Difference 426.3%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Aug 10, 2022. It was a backward split with a ratio of 1:15.

Last Split Date Aug 10, 2022
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -2.15
Piotroski F-Score 2